Molecular Pathology and Targeted Therapies for Personalized Management of Central Nervous System Germinoma
Molecular Pathology and Targeted Therapies for Personalized Management of Central Nervous System Germinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Molecular Pathology and Targeted Therapies for Personalized Management of Central Nervous System Germinoma have?
Molecular Pathology and Targeted Therapies for Personalized Management of Central Nervous System Germinoma has 19 citations in the OpenAlex counts ScholarIQ stores.
When was Molecular Pathology and Targeted Therapies for Personalized Management of Central Nervous System Germinoma published?
Molecular Pathology and Targeted Therapies for Personalized Management of Central Nervous System Germinoma has 2021 year in the ScholarIQ index.
What is the open-access status of Molecular Pathology and Targeted Therapies for Personalized Management of Central Nervous System Germinoma?
Molecular Pathology and Targeted Therapies for Personalized Management of Central Nervous System Germinoma has gold oa status in the ScholarIQ index.
What is the DOI of Molecular Pathology and Targeted Therapies for Personalized Management of Central Nervous System Germinoma?
The DOI for Molecular Pathology and Targeted Therapies for Personalized Management of Central Nervous System Germinoma is on the source record.
What is the PMID of Molecular Pathology and Targeted Therapies for Personalized Management of Central Nervous System Germinoma?
The PMID for Molecular Pathology and Targeted Therapies for Personalized Management of Central Nervous System Germinoma is on the source record.
What is the OpenAlex record for Molecular Pathology and Targeted Therapies for Personalized Management of Central Nervous System Germinoma?
The OpenAlex for Molecular Pathology and Targeted Therapies for Personalized Management of Central Nervous System Germinoma is on the source record.